Skip to main content

Table 4 Status on antiplatelet therapy for women diagnosed with AAA, PAD and/or CP

From: A population-based screening study for cardiovascular diseases and diabetes in Danish postmenopausal women: acceptability and prevalence

 

Age group 1 (n = 153)

Age group 2 (n = 197)

Age group 3 (n = 170)

Age group 4 (n = 111)

p value

Already in therapy

36 (23.5)

48 (24.4)

54 (31.8)

44 (39.6)

0.012

Referred to cardiologist

2 (1.3)

0

1 (0.6)

0

0.289

Potential contraindication

15 (9.8)

15 (7.6)

12 (7.1)

16 (14.4)

0.157

Initiation of therapy

55 (36)

69 (35)

64 (37.7)

27 (24.3)

0.112

Hesitation to accept therapy

35 (22.9)

46 (23.4)

33 (19.4)

20 (18)

0.615

No response

10 (6.5)

19 (9.6)

6 (3.5)

4 (3.6)

0.059

  1. Values are n (%). P value refers to the x2 test for difference across age groups